Literature DB >> 7025811

Successful treatment of Candida albicans endophthalmitis with intravitreal amphotericin B.

L E Perraut, L E Perraut, B Bleiman, J Lyons.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7025811     DOI: 10.1001/archopht.1981.03930020439006

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  13 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  [Rational antibiotic therapy in ophthalmology].

Authors:  W Behrens-Baumann; U Frank; T Ness
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

3.  A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating keratoplasty.

Authors:  N K Ragge; J C Hart; D L Easty; A G Tyers
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

4.  Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes.

Authors:  J Baldinger; B H Doft; S A Burns; B Johnson
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

5.  The place of elective vitrectomy in the management of patients with Candida endophthalmitis.

Authors:  T Barrie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

Review 6.  Laboratory diagnosis of invasive candidiasis.

Authors:  J M Jones
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

7.  Candidal endophthalmitis: a manifestation of systemic candidiasis.

Authors:  B C Patel; S B Kaye; L H Morgan
Journal:  Postgrad Med J       Date:  1987-07       Impact factor: 2.401

8.  Fatal disseminated cryptococcosis following intraocular involvement.

Authors:  J A Schulman; C Leveque; M Coats; L Lawrence; J C Barber
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

9.  Nontoxic concentration of amphotericin B for intravitreal use--evaluated by in vitro ERG.

Authors:  K Kawasaki; J Ohnogi; Y Okayama
Journal:  Doc Ophthalmol       Date:  1988-05       Impact factor: 2.379

Review 10.  [Keratomycosis: diagnosis and therapy].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.